Ken K Nischal MD
Neonatal corneal opacities have for many decades suffered the worst fate of our profession;misdiagnosis. The advent of modern anterior segment imaging techniques has revealed that thedevelopmental anomalies of the cornea and anterior segment, so often relegated to the wastepaper basket diagnoses of Peters anomaly and sclerocornea, are much more complex thanoriginally thought. This has led to a novel classification which appears to help with prognsosisand even treatment planning. Moreover by recognizing the fact that infants are a developingneurobilogical system the effects of minimal visual improvement can have profound effects onglobal developemnt of the infant. This lecture will cover this paragdugm shift in classificationand approach.
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY